The relationship between preoperative hemoglobin, albumin, lymphocyte, and platelet (HALP) score and right colon cancer surgery outcomes: a retrospective cohort study

Yıl 2024, Cilt: 10 Sayı: 4, 351 - 360, 04.07.2024

Oğuzhan Fatih Ay , Mehmet Fatih Erol , Sinan Arıcı , Mehmet Karadağ

https://doi.org/10.18621/eurj.1455789

Öz

Objectives: This study aims to investigate the association between the preoperative Hemoglobin Albumin Lymphocyte Platelet (HALP) score and surgical outcomes in right colon cancer patients.

Methods: This retrospective cohort study included patients undergoing elective right colon adenocarcinoma surgery from January 2017 to June 2023 at Bursa Yuksek Ihtisas Training and Research Hospital. The HALP score, calculated from hemoglobin, albumin, lymphocyte, and platelet levels, aimed to predict perioperative morbidity through receiver operating characteristic (ROC) curve analysis.

Results: The study involved 67 patients, mostly male with an average age of 68.28 years, undergoing 46 open and 21 laparoscopic surgeries. Although the HALP score's cutoff value was established, it did not significantly predict perioperative morbidity (P>0.05). However, lower platelet counts (<318×10³/L) and open surgery type correlated significantly with higher morbidity (P<0.05).

Conclusions: This study reveals that the HALP score may not effectively predict perioperative morbidity in right colon cancer surgeries, highlighting platelet counts as a more promising marker. Our findings also confirm the increased morbidity associated with open surgeries, challenging existing assumptions and guiding clinical practice.

Anahtar Kelimeler

Colon cancer, surgery, morbidity, nutrition

Kaynakça

• 1. Tan X, Yang X, Hu S, Chen X, Sun Z. Predictive modeling based on tumor spectral CT parameters and clinical features for postoperative complications in patients undergoing colon resection for cancer. Insights Imaging. 2023;14(1):155. doi: 10.1186/s13244-023-01515-5.
• 2. Bourakkadi Idrissi M, El Bouhaddouti H, Mouaqit O, Ousadden A, Ait Taleb K, Benjelloun EB. Left-Sided Colon Cancer and Right-Sided Colon Cancer: Are They the Same Cancer or Two Different Entities? Cureus. 2023;15(4):e37563. doi: 10.7759/cureus.37563.
• 3. Baidoun F, Elshiwy K, Elkeraie Y, et al. Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes. Curr Drug Targets. 2021;22(9):998-1009. doi: 10.2174/1389450121999201117115717.
• 4. Baran B, Mert Ozupek N, Yerli Tetik N, Acar E, Bekcioglu O, Baskin Y. Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature. Gastroenterology Res. 2018;11(4):264-273. doi: 10.14740/gr1062w. Epub 2018 Feb 8.
• 5. Mik M, Berut M, Dziki L, Trzcinski R, Dziki A. Right- and left-sided colon cancer - clinical and pathological differences of the disease entity in one organ. Arch Med Sci. 2017;13(1):157-162. doi: 10.5114/aoms.2016.58596.
• 6. Hansen IO, Jess P. Possible better long-term survival in left versus right-sided colon cancer - a systematic review. Dan Med J. 2012;59(6):A4444.
• 7. Shinji S, Yamada T, Matsuda A, et al. Recent Advances in the Treatment of Colorectal Cancer: A Review. J Nippon Med Sch. 2022;89(3):246-254. doi: 10.1272/jnms.JNMS.2022_89-310.
• 8. Schneider M, Hübner M, Becce F, et al. Sarcopenia and major complications in patients undergoing oncologic colon surgery. J Cachexia Sarcopenia Muscle. 2021;12(6):1757-1763. doi: 10.1002/jcsm.12771.
• 9. Nunes GD, Cardenas LZ, Miola TM, Souza JO, Carniatto LN, Bitencourt AGV. Preoperative evaluation of sarcopenia in patients with colorectal cancer: a prospective study. Rev Assoc Med Bras (1992). 2023;69(2):222-227. doi: 10.1590/1806-9282.20220339.
• 10. Farag CM, Antar R, Akosman S, Ng M, Whalen MJ. What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP's prognostic ability in different cancer types. Oncotarget. 2023;14:153-172. doi: 10.18632/oncotarget.28367.
• 11. Xu H, Zheng X, Ai J, Yang L. Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: A systematic review and meta-analysis of 13,110 patients. Int Immunopharmacol. 2023;114:109496. doi: 10.1016/j.intimp.2022.109496.
• 12. Gu X, Gao XS, Qin S, et al. Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer. PLoS One. 2016;11(9):e0163523. doi: 10.1371/journal.pone.0163523.
• 13. Chaouch MA, Dougaz MW, Bouasker I, et al. Laparoscopic Versus Open Complete Mesocolon Excision in Right Colon Cancer: A Systematic Review and Meta-Analysis. World J Surg. 2019;43(12):3179-3190. doi: 10.1007/s00268-019-05134-4.
• 14. Kim IY, Kim BR, Choi EH, Kim YW. Short-term and oncologic outcomes of laparoscopic and open complete mesocolic excision and central ligation. Int J Surg. 2016;27:151-157. doi: 10.1016/j.ijsu.2016.02.001.
• 15. Huang JL, Wei HB, Fang JF, Zheng ZH, Chen TF, Wei B, Huang Y, Liu JP. Comparison of laparoscopic versus open complete mesocolic excision for right colon cancer. Int J Surg. 2015;23(Pt A):12-7. doi: 10.1016/j.ijsu.2015.08.037.
• 16. Bae SU, Saklani AP, Lim DR, et al. Laparoscopic-assisted versus open complete mesocolic excision and central vascular ligation for right-sided colon cancer. Ann Surg Oncol. 2014;21(7):2288-2294. doi: 10.1245/s10434-014-3614-9.
• 17. Han DP, Lu AG, Feng H, et al. Long-term outcome of laparoscopic-assisted right-hemicolectomy with D3 lymphadenectomy versus open surgery for colon carcinoma. Surg Today. 2014;44(5):868-874. doi: 10.1007/s00595-013-0697-z.
• 18. Zhao LY, Chi P, Ding WX, et al. Laparoscopic vs open extended right hemicolectomy for colon cancer. World J Gastroenterol. 2014;20(24):7926-7932. doi: 10.3748/wjg.v20.i24.7926.
• 19. Shin JK, Kim HC, Lee WY, et al. Laparoscopic modified mesocolic excision with central vascular ligation in right-sided colon cancer shows better short- and long-term outcomes compared with the open approach in propensity score analysis. Surg Endosc. 2018;32(6):2721-2731. doi: 10.1007/s00464-017-5970-6.
• 20. Sheng QS, Pan Z, Chai J, et al. Complete mesocolic excision in right hemicolectomy: comparison between hand-assisted laparoscopic and open approaches. Ann Surg Treat Res. 2017;92(2):90-96. doi: 10.4174/astr.2017.92.2.90.
• 21. Chen Z, Sheng Q, Ying X, Chen W. Comparison of laparoscopic versus open complete mesocolic excision in elderly patients with right hemicolon cancer: retrospective analysis of one single cancer. Int J Clin Exp Med. 2017;10(3):5116-5124.
• 22. Zedan A, Elshiekh E, Omar MI, et al. Laparoscopic versus Open Complete Mesocolic Excision for Right Colon Cancer. Int J Surg Oncol. 2021;2021:8859879. doi: 10.1155/2021/8859879.
• 23. Li T, Meng X_L, Chen W. Safety and Short-term Efcacy of a Laparoscopic Complete Mesocolic Excision for the Surgical Treatment of Right Hemicolon Cancer. Clin Surg Res Commun. 2018;2(2):29-33. doi: 10.31491/CSRC.2018.6.016.
• 24. Calderillo Ruiz G, Lopez Basave H, Vazquez Renteria RS, et al. The Prognostic Significance of HALP Index for Colon Cancer Patients in a Hispanic-Based Population. J Oncol. 2022;2022:4324635. doi: 10.1155/2022/4324635.
• 25. Yalav O, Topal U, Unal AG, Eray IC. Prognostic significance of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients undergoing curative resection for colorectal cancer. Ann Ital Chir. 2021;92:283-292.
• 26. Jiang H, Li H, Li A, et al. Preoperative combined hemoglobin, albumin, lymphocyte and platelet levels predict survival in patients with locally advanced colorectal cancer. Oncotarget. 2016;7(44):72076-72083. doi: 10.18632/oncotarget.12271.
• 27. Li Z, Xu Z, Huang Y, et al. Prognostic values of preoperative platelet-to-lymphocyte ratio, albumin and hemoglobin in patients with non-metastatic colon cancer. Cancer Manag Res. 2019;11:3265-3274. doi: 10.2147/CMAR.S191432.
• 28. Min GT, Wang YH, Yao N, et al. The prognostic role of pretreatment platelet-to-lymphocyte ratio as predictors in patients with colorectal cancer: a meta-analysis. Biomark Med. 2017;11(1):87-97. doi: 10.2217/bmm-2016-0181.
• 29. Zhou X, Du Y, Huang Z, et al. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One. 2014;9(6):e101119. doi: 10.1371/journal.pone.0101119.